T-cell-based immunotherapy in colorectal cancer
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 498, 201-209
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81872895, RO-MY201712, 18ZR1403900)
- Science and Technology Commission of Shanghai Municipality (81872895, RO-MY201712, 18ZR1403900)
This publication has 97 references indexed in Scilit:
- E-type prostanoid receptor 4 (EP4) in disease and therapyPharmacology & Therapeutics, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Drugging Wnt signalling in cancerThe EMBO Journal, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Intelligent Design: Combination Therapy With Oncolytic VirusesMolecular Therapy, 2010
- Viruses as anticancer drugsTrends in Pharmacological Sciences, 2007
- Altered macrophage differentiation and immune dysfunction in tumor developmentJournal of Clinical Investigation, 2007
- Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myelomaProceedings of the National Academy of Sciences, 2007
- MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer modelVaccine, 2007